NCT04561570View on ClinicalTrials.gov

Long Term Outcomes of Vivity Intra Ocular Lens(IOL) Versus Control

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions
Cataract
Interventions
DEVICE

Vivity ACRYSOF IQ IOL Group

Subjects that were implanted with the Vivity ACRYSOF IQ extended depth of focus IntaOcular Lens

DEVICE

ACRYSOF IQ IOL Control Group

Subject that were implanted with the ACRYSOF IQ Monofocal IntaOcular Lens

Trial Locations (1)

57108

Vance Thompson Vision, Sioux Falls

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

collaborator

The Eye Associates

OTHER

collaborator

Eye Care Specialists

UNKNOWN

collaborator

NewsomeEye

UNKNOWN

lead

John Berdahl, MD

OTHER